Using ICC, we confirmed that the a-SMA and COL1A1 protein levels in the LX-2 cells increased significantly after TGF-β1 treatment, which were then significantly mitigated by hsa_circ_0009096 siRNA (Fig. 4G). The gene discussed is TGFB1; the disease is intrahepatic cholangiocarcinoma.